Head-to-head comparisons of medication uses, side effects, warnings, and more.
Rizatriptan (Maxalt) and Treximet (sumatriptan/naproxen) are both used to treat migraines, but they have some key differences. Rizatriptan (Maxalt) is a triptan that works by tightening blood vessels and reducing inflammation in the brain. It is available as a generic and comes in both tablet and orally disintegrating tablet (ODT) forms. Treximet, on the other hand, combines sumatriptan, another triptan, with naproxen, a non-steroidal anti-inflammatory drug (NSAID). This combination helps to both shrink blood vessels and reduce pain and inflammation. Treximet is only available as tablet that you swallow, but like Rizatriptan, is available in a lower-cost generic form. While rizatriptan can be used by children as young as 6 years old, Treximet is approved for use in people aged 12 and older. Both medications can cause dizziness and sleepiness, but Treximet has additional risks like stomach bleeding due to the NSAID component.
Rizatriptan (Maxalt) is used to treat migraines with or without aura in people ages 6 years and older. Rizatriptan (Maxalt) is available as a lower-cost generic tablet and an orally disintegrating tablet (ODT) that's placed on the tongue. Common side effects include dizziness, headache, and sleepiness. It can interact with antidepressants and other similar migraine medications.
Treximet helps treat migraine in people age 12 years and older. It's a tablet that has two main ingredients: sumatriptan and naproxen. Sumatriptan is a triptan, and naproxen is a nonsteroidal anti-inflammatory drug (NSAID). These ingredients work together to treat migraine symptoms. Treximet is taken by mouth at the first sign of a migraine. Side effects aren't common but can include dizziness, sleepiness, and nausea. Treximet is available as a brand-name and generic medication.
Adults:
Children:
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.